This tag is associated with 42 posts

Obesity policy in the EU

Written by Adela Maghear and Teresa Lopez Garcia At the present time, more than half (52%) of the adult population in the European Union (EU) is overweight or obese (2012 data ). Persons who are overweight or obese have excessive weight which can lead to important health risks due to a high proportion of body fat. Overweight … Continue reading

Medicinal products in the European Union: The legal framework for medicines for human use

Written by Nicole Scholz A high level of protection for human health is a central objective of European Union (EU) public health policy. To guarantee this objective, high standards of quality and safety for medicinal products are essential. Although pharmaceuticals are primarily regulated at the national level by the Member States, there is a large body of EU legislation … Continue reading

eHealth – Technology for health

Written by Nicole Scholz ‘eHealth’ is a recently-coined term for the use of information and communication technology (ICT) in health, and refers to an interdisciplinary field with multiple uses. It aims to improve the quality of healthcare and make health systems more efficient and effective. For patients, eHealth has the potential to bring them improved … Continue reading

STOA Workshop – The Ebola Outbreak: Challenges and Perspectives

Written by Gianluca Quaglio and Geoff Archer. The Ebola crisis has topped media and political agendas as a number of countries in West Africa experience the worst Ebola epidemic in history. The European Parliament’s Science and Technology Options Assessment (STOA) Panel is organising a workshop on 4 March 2015 with experts from international institutions and NGOs … Continue reading

A new STOA Panel for the new European Parliament

The European Parliament’s Science and Technology Options Panel (known as STOA) has had its political leadership mandate renewed for the next two and a half years at a constituent meeting held during the recent European Parliament (EP) plenary session week in Strasbourg. On 22nd October 2014, MEPs appointed to the STOA Panel by parliamentary committees … Continue reading

Health and technology in life sciences

We are seeing developments in biotechnology that seem futuristic, such as computing systems at clinical testing stages used as ‘sensitive interaction partners’ for the elderly that help to provide care in response to individual needs. Such developments raise a range of questions. To what extent should humans use technology to enhance life? And how can … Continue reading

EU health programme for 2014 to 2020

6 language versions available in PDF format Gesundheitsprogramm der EU für 2014 bis 2020 Programa de Salud de la UE 2014-2020 Le programme de l’Union européenne dans le domaine de la santé 2014-2020 Programma dell’UE in materia di sanità 2014 2020 Program działań UE w dziedzinie zdrowia na lata 2014–2020 EU health programme for 2014 … Continue reading

Safe and innovative medical devices

6 language versions available in PDF format Unbedenkliche und innovative Medizinprodukte Productos sanitarios innovadores y seguros Dispositifs médicaux sûrs et innovants Dispositivi medici sicuri e innovativi Bezpieczne i innowacyjne wyroby medyczne Safe and innovative medical devices Innovation in medical devices benefits patients, doctors and the medical technology industry. The European Commission has proposed legis­lation aimed … Continue reading

Gestion du risque d’épidémie dans l’UE

Certaines maladies peuvent provoquer une épidémie dans la population humaine, lorsqu’elles se transmettent facilement et rapidement dans la population. Certaines maladies contagieuses, qu’elles soient bien connues ou émergentes, pouvant se propager en épidémie constituent un risque pour la santé publique. Ce risque d’épidémie existe à l’échelle mondiale, avec les voyages qui relient en peu de … Continue reading

Essais cliniques: révision de la réglementation: Simplifier tout en maintenant la sûreté et la sécurité

La révision de la réglementation européenne sur les essais cliniques était attendue par toutes les parties intéressées. Elle conclut un processus d’évaluation de la directive 2001/20/CE, mené par la Commission à travers des consultations auxquelles la plupart des acteurs des essais cliniques (médecins, patients, industrie, organes de recherche) ont contribué. L’objectif de la proposition de … Continue reading

Financing and providing long-term care: The challenge of an ageing population

Older people are not the only people in need of long-term care (LTC), but in terms of numbers, they represent the greatest need. As more people live longer, the demand for LTC in Europe is expected to increase significantly. Paying for and providing quality care will be important challenges as the proportion of the population … Continue reading

Safety and health at work: 2007-2012 EU strategy evaluated

On 31 May 2013, the European Commission launched a public consultation on a 2013-2020 strategy on safety and health at work. At the same time, the results of the evaluation of the 2007-2012 strategy were published. They suggest that a post-2012 framework is clearly needed, as all EU Member States face similar challenges. Outcome of … Continue reading

Electromagnetic fields: worker health and safety

Electromagnetic fields can have short-term health effects on people working in close proximity to them. A 2004 Directive designed to protect workers’ safety created problems for the health sector. A proposed new Directive provides derogations for some applications while safeguarding workers’ health and safety. Electromagnetic fields and health Electromagnetic fields (EMFs) are produced by natural … Continue reading

Electronic cigarettes

Electronic cigarettes (e-cigarettes) work by vaporising nicotine liquid. They are aimed at people who do not want to smoke tobacco but cannot or do not want to overcome their nicotine addiction. They are mostly produced in China, and marketed in Europe by small and medium-sized firms. The market is growing rapidly. The variety of products … Continue reading

Making tobacco less attractive: Revision of the Tobacco Products Directive

Smoking is the leading cause of preventable diseases in the EU. Tobacco-related diseases kill around 700 000 Europeans per year. Measures to reduce smoking include taxation, restrictions on advertising, health warnings, education and awareness-raising campaigns and smoking bans in public places. Some 175 countries and the EU have signed the UN Framework Convention on Tobacco … Continue reading

EU policy on endocrine disruptors

Endocrine disruptors (EDs) are substances that disturb the functioning of hormones, and are associated with various human health problems, including reduced fertility and reproductive abnormalities. EDs can act at very low doses and are especially dangerous during pregnancy and in infancy. Despite intensive research efforts, there are still major gaps in understanding of endocrine disruption … Continue reading

Control of swine fever in the EU

Classical swine fever (CSF) and African swine fever (ASF) are two highly transmissible viral diseases affecting domestic pigs and wild boar, with major economic consequences on pig farming and on pig-product markets. These diseases are not transmissible to humans. At global level, trans-border animal diseases fall under the remit of the World Animal Health Organisation. … Continue reading

European and Developing Countries Clinical Trials Partnership (EDCTP): Lessons learnt and perspectives

Since its establishment in 2003, the European and Developing Countries Clinical Trials Partnership (EDCTP) has addressed a double challenge. First, a lack of resources for conducting clinical research in the countries most touched by poverty-related diseases (PRD) – malaria, HIV/AIDS and tuberculosis. Second, persistent fragmentation of European research efforts related to PRD. The EDCTP aims … Continue reading

The greener your street, the healthier the environment you live in!

According to a recent research by scientists at the Universities of Birmingham and Lancaster (UK) the ‘greening up’ of our streets could lead to a  massive 30% reduction in urban pollution. Trees, bushes and other greenery growing in the concrete-and-glass ‘urban canyons’ of cities would deliver cleaner air at the roadside where most of us … Continue reading

Know what you shouldn’t buy: no more logos on cigarette packs

Tobacco is the largest single cause of avoidable death, disease and disability in the European Union. It claims the lives of some 650,000 people each year. And yet, even in the face of such scientific evidence, people still smoke. European Union EU legislation on the control of tobacco regulates the marketing of tobacco products for … Continue reading

Download the EPRS App

EPRS App on Google Play
EPRS App on App Store
What Europe Does For You
EU Legislation in Progress
Topical Digests
EPRS Podcasts

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 3,467 other followers

Disclaimer and Copyright statement

The content of all documents (and articles) contained in this blog is the sole responsibility of the author and any opinions expressed therein do not necessarily represent the official position of the European Parliament. It is addressed to the Members and staff of the EP for their parliamentary work. Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy.

For a comprehensive description of our cookie and data protection policies, please visit Terms and Conditions page.

Copyright © European Union, 2014-2019. All rights reserved.